Michihiro Iwaki

13PUBLICATIONS
55CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Metabolic medicineGene and molecular therapyMedical infection agents (incl. prions)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 12, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLD.

Yuya Seko, Taeang Arai, Hirokazu Takahashi

|Dec 12, 2025
Assessing the risk of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: is the Fibrosis-4 index still a reliable tool?

Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki

|Sep 08, 2025
Efficacy of Magnetic Resonance Elastography in Fontan-Associated Liver Disease.

Michihiro Iwaki, Takashi Kobayashi, Naohiro Wada

|Dec 13, 2024
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease.

Hiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada

|Nov 24, 2024
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol.

Michihiro Iwaki, Takashi Kobayashi, Asako Nogami

|Apr 25, 2024
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.

Kazuhiro Nouso, Miwa Kawanaka, Hideki Fujii

Pageof 3

Frequent Collaborators

10 joint publications

Atsushi Nakajima

6 joint publications

Hidenori Toyoda

5 joint publications

Asahiro Morishita

4 joint publications

Takashi Kobayashi